Scott Henry
Stock Analyst at Alliance Global Partners
(1.25)
# 3,774
Out of 5,238 analysts
58
Total ratings
38.46%
Success rate
-6.05%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.73 | +310.57% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $0.91 | +313.63% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $0.66 | +802.53% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $2.37 | +321.94% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $22.50 | +83.33% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $5.07 | +67.65% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.86 | +363.18% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $2.39 | +527.62% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $240 | $0.86 | +27,937.38% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.02 | +24.58% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $11.48 | +13.24% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $31.33 | -23.40% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $221.41 | -59.35% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $31.15 | -50.24% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $107.94 | -46.27% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $86.29 | -58.28% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.03 | +967.96% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.08 | +94.81% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $0.65 | +884,515.38% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.29 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.83 | +745.82% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $14.09 | - | 5 | Apr 18, 2019 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.73
Upside: +310.57%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $0.91
Upside: +313.63%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $0.66
Upside: +802.53%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $2.37
Upside: +321.94%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $22.50
Upside: +83.33%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $5.07
Upside: +67.65%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.86
Upside: +363.18%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $2.39
Upside: +527.62%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $240
Current: $0.86
Upside: +27,937.38%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.02
Upside: +24.58%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $11.48
Upside: +13.24%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $31.33
Upside: -23.40%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $221.41
Upside: -59.35%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $31.15
Upside: -50.24%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $107.94
Upside: -46.27%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $86.29
Upside: -58.28%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.03
Upside: +967.96%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.08
Upside: +94.81%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $0.65
Upside: +884,515.38%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.29
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.83
Upside: +745.82%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $14.09
Upside: -